Transduction of primary cells

Details for Australian Patent Application No. 2006251621 (hide)

Owner VIRxSYS Corporation

Inventors Slepushkin, Vladimir; Humeau, Laurent

Agent FB Rice

Pub. Number AU-A-2006251621

PCT Pub. Number WO2006/127585

Priority 60/683,527 20.05.05 US

Filing date 22 May 2006

Wipo publication date 30 November 2006

International Classifications

C12N 15/867 (2006.01) Mutation or genetic engineering - Retroviral vectors

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

13 December 2007 PCT application entered the National Phase

  PCT publication WO2006/127585 Priority application(s): WO2006/127585

15 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006251623-Pyrrolopyridines useful as inhibitors of protein kinase

2006251620-Imidazolone phenylalanine derivatives as VLA-4 antagonists